{"id":"https://genegraph.clinicalgenome.org/r/3dc1c298-c98b-442d-8488-47fa8eebf689v1.1","type":"EvidenceStrengthAssertion","dc:description":"GRIA3 was first reported in relation to X-linked Intellectual Disability in 1999 (Gecz et al., 10644433). At least 10 probands with missense variants have been reported in 8 publications (31406558, 28708303, 25644381, 26637798, 21376300, 24721225, 29016847, 17989220). In addition, loss of function variants in GRIA3 coding region have been reported in 3 probands (1 nonsense, 1 frameshift and 1 intragenic duplication) in 3 publications (PMIDs 31406558, 25644381, 17568425). The proband with 498Kb duplication variant was unable to be formally scored in the GCI since it is >10Kb in size. Though the genetic evidence score shown in the evidence summary is 7.6 points, it should be 8.6 points to account for this duplication variant that could not be scored. Variants in this gene also segregated with disease in at least 2 families (PMID 17989220). This gene-disease association is supported by animal models and expression studies (10644433, 12848940, 18312590,16436610, 22285418). In summary, there is sufficient evidence to support a definitive association of GRIA3 with X-linked complex neurodevelopmental disorder. The gene-disease association has been demonstrated in multiple reports and animal model studies, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 11/06/19 (SOP Version 7).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3dc1c298-c98b-442d-8488-47fa8eebf689","GCISnapshot":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2021-10-27T13:12:32.736Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2019-11-06T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28f3fcda-f057-480a-8ae2-5baa1fca36a8","type":"EvidenceLine","dc:description":"Functional evidence supporting variant pathogenicity is not provided.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28f3fcda-f057-480a-8ae2-5baa1fca36a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25644381","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce1b9798-ba53-4900-91ca-cbd3086c94a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.2161G>A (p.Gly721Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414264921"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a62b4e75-c0b2-4d34-a8fc-0b3f749f45f2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a62b4e75-c0b2-4d34-a8fc-0b3f749f45f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29016847","allele":{"id":"https://genegraph.clinicalgenome.org/r/51618c8b-e3cf-4dd6-bb78-5f2922ce8f36","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.1957G>A (p.Ala653Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16608259"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a62b4e75-c0b2-4d34-a8fc-0b3f749f45f2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant functional assay showed that mutation stabilize channel in closed confirmation in HEK293 cells. Altered synaptic transmission due to reduced channel activation in CRISPR mouse model. Also showed sleep deficits in mouse models","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9d020453-4379-452f-a7b8-378b8a498fd6","type":"EvidenceLine","dc:description":"Functional evidence supporting variant pathogenicity is not provided.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9d020453-4379-452f-a7b8-378b8a498fd6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26637798","allele":{"id":"https://genegraph.clinicalgenome.org/r/3551365b-71ce-407d-8101-3e58f5e7857c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.670G>C (p.Glu224Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414261864"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/53f01c4b-5e26-4e44-8c36-5cb699f7a222","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53f01c4b-5e26-4e44-8c36-5cb699f7a222_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","allele":{"id":"https://genegraph.clinicalgenome.org/r/b40bc11e-4b88-4b67-8240-1b99f1bade15","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.2497G>A (p.Gly833Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA120933"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/53f01c4b-5e26-4e44-8c36-5cb699f7a222_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"variant functional study shows Reduced expression in HEK293 cells. Also, G833R variant is misfolded at 37 °C. variant in conserved ion channel domain","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/97891bb6-58e9-454f-820e-30291d7a4e1f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97891bb6-58e9-454f-820e-30291d7a4e1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","allele":{"id":"https://genegraph.clinicalgenome.org/r/5248d999-536a-4714-b31e-9607a37f4044","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.2117T>C (p.Met706Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/10358"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}},{"id":"https://genegraph.clinicalgenome.org/r/97891bb6-58e9-454f-820e-30291d7a4e1f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Minimal current was observed for homomeric expression of M706T variant, due to impaired trafficking to cell surface. Variant located in conserved ion channel domain","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/87587f7a-c6fc-4e66-aac7-43eafb16190f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87587f7a-c6fc-4e66-aac7-43eafb16190f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31406558","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc259670-133b-4cd8-b1c4-71b9a5ee57bc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.504del (p.Glu168AspfsTer21)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA915940887"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a2651dca-dce0-4271-b64c-3452048eead9","type":"EvidenceLine","dc:description":"Functional evidence supporting variant pathogenicity is not provided.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2651dca-dce0-4271-b64c-3452048eead9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28708303","allele":{"id":"https://genegraph.clinicalgenome.org/r/9046a3f3-0ad1-4c6b-9b62-c38ee0626ade","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.1964T>C (p.Phe655Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414259845"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1c344aad-9453-4b1c-8fef-ea4fe3b24743","type":"EvidenceLine","dc:description":"Functional evidence supporting variant pathogenicity is not provided.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1c344aad-9453-4b1c-8fef-ea4fe3b24743_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31406558","allele":{"id":"https://genegraph.clinicalgenome.org/r/dad61f01-8662-4712-a81c-b16050fdc083","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.1990C>G (p.Pro664Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414259956"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6bbdbe78-231f-4f67-b0ea-293075ab78dc_family_segregation","type":"FamilyCosegregation","dc:description":"Variant functional assay showed normal electrophysiological properties plus incomplete penetrance (1/2) is geno+/pheno- maternal uncle.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 R450Q-family","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/6bbdbe78-231f-4f67-b0ea-293075ab78dc","type":"Family","rdfs:label":"Wu_2007 R450Q-family"},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0002342"},{"id":"obo:HP_0001533"}],"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/cb44c9e4-d5a7-4604-8f84-5f0a7ed18297_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 M706T family","family":{"id":"https://genegraph.clinicalgenome.org/r/cb44c9e4-d5a7-4604-8f84-5f0a7ed18297","type":"Family","rdfs:label":"Wu_2007 M706T family","member":{"id":"https://genegraph.clinicalgenome.org/r/a6e71b6b-82b4-4772-b756-88ef62cf52b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 M706T IV:4","allele":{"id":"https://genegraph.clinicalgenome.org/r/5248d999-536a-4714-b31e-9607a37f4044"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/97891bb6-58e9-454f-820e-30291d7a4e1f_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001265","obo:HP_0002342","obo:HP_0002460"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a6e71b6b-82b4-4772-b756-88ef62cf52b2"},"publishedLodScore":2,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ad758e86-9435-4fd1-b1bd-157b667149a7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24721225","rdfs:label":"Figure A","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/ad758e86-9435-4fd1-b1bd-157b667149a7","type":"Family","rdfs:label":"Figure A","member":{"id":"https://genegraph.clinicalgenome.org/r/035407b1-90b4-4ef5-8b6c-e70ac058c6de","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24721225","rdfs:label":"III-8","allele":{"id":"https://genegraph.clinicalgenome.org/r/5728c8b9-e86f-4fa0-a935-fb0cb15b0632","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.1888G>C (p.Gly630Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/127195"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0004322","obo:HP_0010864","obo:HP_0100716","obo:HP_0000718"],"previousTesting":true,"previousTestingDescription":"X-exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/077c7f0a-4dc7-4905-b1d5-dd69bd430cff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24721225","allele":{"id":"https://genegraph.clinicalgenome.org/r/5728c8b9-e86f-4fa0-a935-fb0cb15b0632"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0010864","proband":{"id":"https://genegraph.clinicalgenome.org/r/035407b1-90b4-4ef5-8b6c-e70ac058c6de"}},{"id":"https://genegraph.clinicalgenome.org/r/00aa2e8b-c7e6-4377-8d62-4958c4d0be37_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 G833R-family","family":{"id":"https://genegraph.clinicalgenome.org/r/00aa2e8b-c7e6-4377-8d62-4958c4d0be37","type":"Family","rdfs:label":"Wu_2007 G833R-family","member":{"id":"https://genegraph.clinicalgenome.org/r/c964ab80-4149-41e6-ac00-b0d3325719a9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 G833R III:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/b40bc11e-4b88-4b67-8240-1b99f1bade15"},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/53f01c4b-5e26-4e44-8c36-5cb699f7a222_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001336","obo:HP_0002342","obo:HP_0000729","obo:HP_0000256"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/c964ab80-4149-41e6-ac00-b0d3325719a9"}},{"id":"https://genegraph.clinicalgenome.org/r/f8ed28ce-3a15-487f-bc5f-106ff956fb15_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 R631S-family","family":{"id":"https://genegraph.clinicalgenome.org/r/f8ed28ce-3a15-487f-bc5f-106ff956fb15","type":"Family","rdfs:label":"Wu_2007 R631S-family","member":{"id":"https://genegraph.clinicalgenome.org/r/838c35ce-d1cd-428c-96c8-75dc162074dc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","rdfs:label":"Wu_2007 R631S II:1","allele":{"id":"https://genegraph.clinicalgenome.org/r/2cad5304-a68f-4a48-bf85-76ab374d5e30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007325.5(GRIA3):c.1891C>A (p.Arg631Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/10357"}},"detectionMethod":"Targeted GRIA full gene sequencing.\nGenomic DNA was extracted from lymphoblast\ncell lines. For each sample, 17 exons of GRIA3 (NM007325, flip;\nNM000228, flop) with 150-bp flanking introns were PCR-amplified\nusing HotMaster TaqDNA polymerase (Eppendorf, Boulder, CO)\naccording to the manufacturer’s instruction. PCR amplicons and\nprimer sequences are provided in SI Table 1. PCR products were\npurified by Exo1/SAP following a standard protocol (Applied\nBiosystems, Foster City, CA). Sequencing was performed using\nABI PRISM BigDye Terminator Cycle Sequencing kit on an\nABI3100 automatic DNA sequencer (Applied Biosystems).","firstTestingMethod":"PCR","phenotypes":"obo:HP_0002342","previousTesting":true,"previousTestingDescription":"Negative for Fragile X","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/57d91f44-fd06-4e60-bb22-944380002ef9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989220","allele":{"id":"https://genegraph.clinicalgenome.org/r/2cad5304-a68f-4a48-bf85-76ab374d5e30"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001265","obo:HP_0001256","obo:HP_0002342","obo:HP_0002460","obo:HP_0001533"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/838c35ce-d1cd-428c-96c8-75dc162074dc"},"publishedLodScore":2,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fb5e8c11-3800-476b-ace7-10c18e8cc3c3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb5e8c11-3800-476b-ace7-10c18e8cc3c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25644381","allele":{"id":"https://genegraph.clinicalgenome.org/r/a13d596a-8c16-404f-bcff-52ad29261463","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.670G>T (p.Glu224Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414261861"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/57d91f44-fd06-4e60-bb22-944380002ef9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/57d91f44-fd06-4e60-bb22-944380002ef9_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/57d91f44-fd06-4e60-bb22-944380002ef9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant functional analysis showed that minimal current was observed for homomeric expression of R631S.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/077c7f0a-4dc7-4905-b1d5-dd69bd430cff","type":"EvidenceLine","dc:description":"There is no variant evidence to support that this mutation affects the function of GRIA3. Plus, there are mutations in other genes that co-segregate that are associated with XLID, including TAF2 (MRX33, although the N1789S mutation is predicted to be benign). LRCH2 is not associated with any disease per OMIM, and in Exac the LRCH2-E261K mutation has an overall freq= 0.4%, and in Finnish is 0.019, or 2%, so likley benign. Classify as VUS.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/077c7f0a-4dc7-4905-b1d5-dd69bd430cff_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5625901f-c6fa-49da-956b-4134dd6176a8","type":"EvidenceLine","dc:description":"Functional evidence supporting variant pathogenicity is not provided.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5625901f-c6fa-49da-956b-4134dd6176a8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21376300","allele":{"id":"https://genegraph.clinicalgenome.org/r/896486fe-68c0-4ef9-865a-df951cbd3fb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000828.4(GRIA3):c.2266G>T (p.Gly756Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414265478"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":7.6},{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ea12663-0536-4217-8547-75d1c217321e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0084c18b-481f-4fa2-92c6-0ceb3fa4d25b","type":"Finding","dc:description":"Northern Blot analysis of adult and fetal brain showed restricted expression of GRIA3 in brain.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10644433","rdfs:label":"Northern blot","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e497c4c-8e51-4766-9eab-2604d7d4135b","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0cada48c-e828-472f-8f92-ed06b3efce98","type":"Finding","dc:description":"GRIA KO mice showed enhanced LTP in the absence of changes to LTD. They also showed susceptibility to seizures (during wakefulness) and behavioral deficits.  Model showed deficit in distance traveled in the open field assay, Less time immobile in forced swimming test.\nOther mouse models of ID/autism genes have shown change to LTP (enhancement or repression) with normal LTD and basal transmission.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12848940","rdfs:label":"LTP, Open Field Assay, Forced Swimming Test","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/402dc1ff-c5e9-4520-94e0-24a73baee8eb","type":"EvidenceLine","dc:description":"GRIA3 mice were “indistinguishable” from their WT littermate. Memory/learning abilities  KO mice were similar to wt.\nHowever KO mice showed decreased locomotion which seems consistent with the humans with GRIA3 mutations, who have hypotonia and locomotion delays.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/837c720d-a062-4d97-b177-a6c2cdb96967","type":"Finding","dc:description":"The decreased locomotion in the mouse model seems consistent with the humans with GRIA3 mutations, who have hypotonia and locomotion delays.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16436610","rdfs:label":"Open field assay, Rotarod, Balance beam, Western blot","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4d311fcc-de38-4f19-9790-bbb5a24aa7bd","type":"EvidenceLine","dc:description":"I gave partial points for this mouse model and study, as while they show motor deficits (consistent with other mouse models and with the probands with ID) and increased aggression, they do not see change in learning and memory.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5daad917-29a2-48b1-b2e4-6dfcbd2a44b6","type":"Finding","dc:description":"The Gria3 knockout mice show motor deficits, which is consistent with other mouse models and with the probands with ID.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22285418","rdfs:label":"Behavioral assays","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":3549,"specifiedBy":"GeneValidityCriteria7","strengthScore":11.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/6-iT35DJUsE","type":"GeneValidityProposition","disease":"obo:MONDO_0100148","gene":"hgnc:4573","modeOfInheritance":"obo:HP_0001417"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_25f94660-0a8d-4f3a-8f6c-dde1b38a8ab7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}